期刊文献+

重症监护室革兰阴性杆菌的分布和耐药分析 被引量:1

Distribution and drug resistance analysis of Gram-negative bacteria in ICU
原文传递
导出
摘要 目的:了解我院重症监护室(ICU)2006年-2010年革兰阴性菌的分布和耐药情况。方法:细菌由VITEK全自动鉴定仪鉴定,采用纸片扩散法(K-B法)进行药敏试验。结果:1639株革兰阴性菌中,前4位分别为A.baumanii占26.1%,P.aeruginosa占16.2%,K.pneumomiae占15.0%,E.coli占11.3%,产ESBLs的K.pneumomiae和E.coli的检出率分别为36.2%和62.9%。结论:ICU患者以呼吸道多重耐药非发酵菌感染为主。 Objective:To investigate the distribution and drug resistance of Gram-negative bacteria in the department of ICU in our hospital for improving the management and proper clinical utilization.Methods: The bacteria isolates were identified by VITEK automatic analyzer,Kirby-Bauer method was used for drug sensitivity test.Results: In 1639 strains of Gram negative bacteria,the above four bacteria were A.baumanii(26.1%),P.aeruginosa(16.2%),K.pneumomiae(15.0%) and E.coli(11.3%).The detection rate of K.pneumomiae and E coli producing ESBLs were 36.2% and 62.9% respectively.Conclusion: Among the ICU patients,the majority were respiratory tract infection caused by multi-resistance nonfermenters.
作者 王宗欣
出处 《中国卫生检验杂志》 CAS 2011年第12期2993-2994,2997,共3页 Chinese Journal of Health Laboratory Technology
关键词 重症监护室 革兰阴性菌 耐药性 ICU Gram-negative bacteria Resistance
  • 相关文献

参考文献7

  • 1年华,褚云卓,王倩.ICU与非ICU病房致病细菌谱及耐药分析[J].中国公共卫生,2007,23(12):1516-1517. 被引量:45
  • 2Yu YS, Ji SJ, Chen YG, et al. Resistance of strains producing extend- ed - spectrum beta - lactamasesand genotype distribution in China [ J ]. J Infect, 2007, 54(1 ):53-57.
  • 3Yang H, Chen H, Yang Q, et al. High prevalence of plasmid - medi- ated quinolone resistance genes qnr and aac(6') -lb -cr in clinical i- solates of Enterobacteriaceae from nine teaching hospitals in China[ J ]. Antimicrob Agents Chemother, 2008, 52(12) :4268 -4273.
  • 4Wei ZQ, Du XX, Yu YS, et al. Plasmid -mediated KPC -2 in a Klebsiellapneumoniae isolate from China[J]. Antimicrob Agente Che- mother, 2007, 51 (2) :763 - 765.
  • 5杨青,徐小微,俞云松,孔海深,徐根云,钟步云.碳青霉烯类耐药鲍曼不动杆菌流行病学及碳青霉烯酶类型的研究[J].中华检验医学杂志,2003,26(6):342-345. 被引量:111
  • 6Wang H, Guo P, Sun H, et al. Molecular epidemiology of clinical iso- lates of carbapenem - resistant Acinetobacter spp. From Chinese hospi- tal [ J ]. Antimicrob Agents Chemother, 2007, 51 ( 11 ) :4022 - 4028.
  • 7杨青,魏泽庆,俞云松,钟步云,陈亚岗,李兰娟.重症监护病房产VIM-2型金属酶绿脓假单胞菌的研究[J].中华检验医学杂志,2004,27(10):678-682. 被引量:36

二级参考文献23

  • 1王敏,程苏琴,陈立敏.危重症监护室呼吸机相关性肺炎病原菌研究[J].中国公共卫生,2004,20(6):665-667. 被引量:7
  • 2李慧,丁钰,于维林,刘蓬蓬,张向华,孙伟.ICU患者病原菌感染情况与耐药性分析[J].山东医药,2004,44(29):34-35. 被引量:8
  • 3Forster DH, Daschner FD. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis, 1998,17:73-77.
  • 4Afzal-Shah M, Livermore DM. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother, 1998,41:576-577.
  • 5Seifert H, Gerner-Smidt P. Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates. J Clin Microbiol, 1995,33 : 1402-1407.
  • 6Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis:criteria for bacterial strain typing. J Clin Microbiol,1995,33:2233-2239.
  • 7Afzal-Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 2001,45 :583-588.
  • 8Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents, 2003,21:58-62.
  • 9Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect, 2002,8:321-331.
  • 10Donald HM, Scaife W, Amyes SG. et al. Sequence analysis of ARI-1, a novel OXA beta -lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother,2000,44:196-199.

共引文献189

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部